SSWM
REGN icon

Sheets Smith Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Sheets Smith Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$811K Buy
1,300
+1
+0.1% +$681 0.08% 232
2026
Q1 		$1M Buy
1,299
+2
+0.2% +$1.53K 0.11% 190
2025
Q4 		$1M Sell
1,297
-20
-2% -$13.6K 0.11% 180
2025
Q3 		$741K Buy
1,317
+36
+3% +$20.4K 0.08% 223
2025
Q2 		$673K Buy
1,281
+55
+4% +$30.7K 0.08% 234
2025
Q1 		$778K Buy
1,226
+66
+6% +$45.4K 0.1% 190
2024
Q4 		$826K Buy
1,160
+45
+4% +$37.8K 0.1% 177
2024
Q3 		$1.17M Hold
1,115
– – 0.14% 138
2024
Q2 		$1.17M Buy
1,115
+57
+5% +$55.3K 0.14% 144
2024
Q1 		$1.02M Buy
1,058
+601
+132% +$571K 0.11% 163
2023
Q4 		$401K Buy
457
+7
+2% +$5.76K 0.06% 255
2023
Q3 		$370K Hold
450
– – 0.06% 246
2023
Q2 		$323K Hold
450
– – 0.05% 269
2023
Q1 		$370K Hold
450
– – 0.06% 236
2022
Q4 		$325K Hold
450
– – 0.05% 246
2022
Q3 		$310K Hold
450
– – 0.05% 239
2022
Q2 		$266K Hold
450
– – 0.04% 258
2022
Q1 		$314K Hold
450
– – 0.04% 275
2021
Q4 		$284K Hold
450
– – 0.04% 314
2021
Q3 		$272K Hold
450
– – 0.04% 315
2021
Q2 		$251K Sell
450
-65
-13% -$32.9K 0.03% 323
2021
Q1 		$244K Hold
515
– – 0.04% 298
2020
Q4 		$249K Buy
+515
New +$278K 0.04% 297
2017
Q3 		– Sell
-2,395
Closed -$1.18M – 315
2017
Q2 		$1.18M Buy
+2,395
New +$1.05M 0.31% 89

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sheets Smith Wealth Management's REGN Position: Q2 2026 in Review

Sheets Smith Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.08% in Q2 2026, buying an estimated $681 and bringing the position to 1,300 shares worth $811K. The position accounts for 0.08% of the portfolio, ranked #232.

Sheets Smith Wealth Management first reported a position in REGN in Q2 2017 and has held it in 24 quarters since. The position peaked at $1.18M in Q2 2017. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Sheets Smith Wealth Management held 1,300 shares of Regeneron Pharmaceuticals worth $811K as of Q2 2026.
  • Sheets Smith Wealth Management bought 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up 0.08% of Sheets Smith Wealth Management's portfolio in Q2 2026, its #232 holding.
  • Sheets Smith Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 24 quarters since.
  • Sheets Smith Wealth Management's Regeneron Pharmaceuticals position peaked at $1.18M in Q2 2017.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.